IAN
JAZZ icon

Integrated Advisors Network’s Jazz Pharmaceuticals JAZZ Stock Holding History

Integrated Advisors Network’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,942
Closed -$354K – 716
2024
Q1 		$354K Buy
+2,942
New +$360K 0.02% 559

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Integrated Advisors Network's JAZZ Position: Q2 2024 in Review

Integrated Advisors Network sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 2,942 shares — an estimated $354K sold.

Integrated Advisors Network first reported a position in JAZZ in Q1 2024 and held it in 1 quarter. The position peaked at $354K in Q1 2024. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Integrated Advisors Network reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Integrated Advisors Network sold 2,942 Jazz Pharmaceuticals shares in Q2 2024, an estimated $354K.
  • Integrated Advisors Network first reported a position in Jazz Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Integrated Advisors Network's Jazz Pharmaceuticals position peaked at $354K in Q1 2024.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Integrated Advisors Network's 13F filing for Q2 2024, filed 9 Aug 2024.